NCT06802523 2026-03-18Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 1 Suspended53 enrolled